Orexo AB
556500-0600ActiveDeveloping innovative medicines using proprietary drug delivery technology.
Overview
- 50–99
- Employees
- 100–500M SEK
- Revenue
- 1994
- Founded
Key Decision Makers
Nikolaj Sørensen
President and CEO
Greta Alina Kampe
Director Business Development
Lena Wange
IR & Corporate Communications Director
Jonas Sävmarker
Scientific Director
+16 more contacts in Funnelfeedr
Description
Orexo is a Swedish biotechnology company focused on advancing treatments for severe diseases and developing life-saving rescue medications. The core of their innovation lies in their proprietary AmorphOX ® drug delivery technology. This technology significantly improves the bioavailability and stabi...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556500060001
- Address
- BOX 303, 751 05, UPPSALA, SE
Decision Makers
20 contacts in FunnelfeedrNikolaj Sørensen
President and CEO
Greta Alina Kampe
Director Business Development
Lena Wange
IR & Corporate Communications Director
Jonas Sävmarker
Scientific Director
Raheleh Nassaji
SVP Business Development
Robert A. DeLuca
President Orexo US Inc.
Fredrik Järrsten
EVP & Chief Financial Officer
Robert Coburn
Head of Business Development
Lisa Moore
SVP Product and Portfolio Strategy
Robert DeLuca
President of Orexo US Inc.
Robert Rönn
SVP Head of R&D
Salem Tewolde
Head of Supply Chain
Robin Evers
Board member
Edward Kim
SVP Chief Medical Officer
Cecilia Coupland
SVP Head of Operations
Staffan Lindstrand
Board member
Christine Rankin
Board member
Fred George Wilkinson
Board member
Dr. Friedrich von Bohlen und Halbach
Chairman of the Board
Other Contacts
Anneli Wennman
Senior Analytical Chemist
Similar Companies
20 similar companies in Funnelfeedr
INSTITUT PRODUITS SYNTHESE (IPSEN) AB
6 employeesGlobal biopharma accelerating innovative medicines for high unmet needs.
VIFOR PHARMA NORDISKA AB
Global leader developing innovative therapies for iron deficiency and kidney disease.
Cereno Scientific AB
10–19 employeesPioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
Oblique Therapeutics AB (publ)
10–19 employeesInnovative biotech developing breakthrough antibodies using the AbiProt platform.
BioCryst Sweden filial till BioCryst Ireland Limited
1–4 employeesGlobal biotech developing novel oral medicines for rare diseases.
Browse More
Orexo AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo